Two sides of one coin: Massive hepatic necrosis and progenitor cell-mediated regeneration in acute liver failure

Frontiers in Physiology

Volumn 6, Issue MAY, 2015, Pages

  Weng, Honglei ^a   Cai, Xiaobo ^a   Yuan, Xiaodong ^a   Liebe, Roman ^a   Dooley, Steven ^a   Li, Hai ^b   Wang, Tai Ling ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Acute liver failure; Acute on chronic liver failure; Liver progenitor cell; Liver Regeneration; Massive Hepatic Necrosis

Indexed keywords

ACUTE LIVER FAILURE; ACUTE ON CHRONIC LIVER FAILURE; DISEASE CLASSIFICATION; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER NECROSIS; LIVER PROGENITOR CELL; LIVER REGENERATION; NONHUMAN; PATHOGENESIS; REVIEW; STEM CELL;

EID: 84930632392     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2015.00178     Document Type: Review

References (96)

1. Craig, C. E. et al. The histopathology of regeneration in massive hepatic necrosis. Seminars in liver disease 24, 49-64, doi:10.1055/s-2004-823101 (2004).
2. Horney, J. T. & Galambos, J. T. The liver during and after fulminant hepatitis. Gastroenterology 73, 639-645 (1977).
3. Kalk, H. Biopsy findings during and after hepatic coma and after acute necrosis of the liver. Gastroenterology 36, 214-218 (1959).
4. Sugawara, K., Nakayama, N. & Mochida, S. Acute liver failure in Japan: definition, classification, and prediction of the outcome. Journal of gastroenterology 47, 849-861, doi:10.1007/s00535-012-0624-x (2012).
5. Popper, H. & Elias, H. Histogenesis of hepatic cirrhosis studied by the threedimensional approach. The American journal of pathology 31, 405-441 (1955).
6. Desmet, V. J. Ductal plates in hepatic ductular reactions. Hypothesis and implications. III. Implications for liver pathology. Virchows Archiv: an international journal of pathology 458, 271-279, doi:10.1007/s00428-011-1050-9 (2011).
7. Desmet, V. J. Ductal plates in hepatic ductular reactions. Hypothesis and implications. I. Types of ductular reaction reconsidered. Virchows Archiv: an international journal of pathology 458, 251-259, doi:10.1007/s00428-011-1048-3 (2011).
8. Clouston, A. D., Jonsson, J. R. & Powell, E. E. Hepatic progenitor cell-mediated regeneration and fibrosis: chicken or egg?. Hepatology 49, 1424-1426, doi:10.1002/hep.22893 (2009).
9. Lucke, B. The Pathology of Fatal Epidemic Hepatitis. The American journal of pathology 20, 471-593 (1944).
10. Lucke, B. & Mallory, T. The Fulminant Form of Epidemic Hepatitis. The American journal of pathology 22, 867-945 (1946).
11. Li, H. et al. Submassive hepatic necrosis distinguishes HBVassociated acute-on chronic liver failure from cirrhotic patients with acute decompensation. Journal of hepatology, doi:10.1016/j.jhep.2015.01.029 (2015).
12. Chenard-Neu, M. P. et al. Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure-a multicenter European study. Hepatology 23, 1119-1127, doi:10.1002/hep.510230528 (1996).
13. Hanau, C., Munoz, S. J. & Rubin, R. Histopathological heterogeneity in fulminant hepatic failure. Hepatology 21, 345-351 (1995).
14. Alastair D. Burt, B. C. P., Linda D. Ferrel. MacSween's Pathology of the Liver, 6th ed. 6th edn, (2012).
15. Stravitz, R. T. et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 53, 517-526, doi:10.1002/hep.24080 (2011).
16. Schulze-Osthoff, K. & Bantel, H. Necrosis versus apoptosis in acetaminophen-induced hepatotoxicity. Hepatology 53, 1070, doi:10.1002/hep.24027 (2011).
17. Bantel, H. & Schulze-Osthoff, K. Mechanisms of cell death in acute liver failure. Frontiers in physiology 3, 79, doi:10.3389/fphys.2012.00079 (2012).
18. Ryo, K. et al. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. The American journal of gastroenterology 95, 2047-2055, doi:10.1111/j.1572-0241.2000.02268.x (2000).
19. Streetz, K. et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 119, 446-460 (2000).
20. Tokushige, K. et al. Significance of soluble TNF receptor-I in acutetype fulminant hepatitis. The American journal of gastroenterology 95, 2040-2046, doi:10.1111/j.1572-0241.2000.02270.x (2000).
21. Nakae, H., Narita, K. & Endo, S. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure. Journal of critical care 16, 59-63, doi:10.1053/jcrc.2001.25470 (2001).
22. Volkmann, X. et al. Caspase activation is associated with spontaneous recovery from acute liver failure. Hepatology 47, 1624-1633, doi:10.1002/hep.22237 (2008).
23. Strand, S. et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nature medicine 4, 588-593 (1998).
24. Rivero, M. et al. Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus. Journal of viral hepatitis 9, 107-113 (2002).
25. Hinson, J. A., Roberts, D. W. & James, L. P. Mechanisms of acetaminophen-induced liver necrosis. Handbook of experimental pharmacology, 369-405, doi:10.1007/978-3-642-00663-0_12 (2010).
26. Luedde, T., Kaplowitz, N. & Schwabe, R. F. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 147, 765-783 e764, doi:10.1053/j.gastro.2014.07.018 (2014).
27. Pasparakis, M. & Vandenabeele, P. Necroptosis and its role in inflammation. Nature 517, 311-320, doi:10.1038/nature14191 (2015).
28. Wang, H. et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Molecular cell 54, 133-146, doi:10.1016/j.molcel.2014.03.003 (2014).
29. Ramachandran, A. et al. Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 58, 2099-2108, doi:10.1002/hep.26547 (2013).
30. Farci, P. et al. B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure. Proceedings of the National Academy of Sciences of the United States of America 107, 8766-8771, doi:10.1073/pnas.1003854107 (2010).
31. Gouw, A. S., Clouston, A. D. & Theise, N. D. Ductular reactions in human liver: Diversity at the interface. Hepatology 54, 1853-1863, doi:10.1002/hep.24613 (2011).
32. Itoh, T. & Miyajima, A. Liver regeneration by stem/progenitor cells. Hepatology 59, 1617-1626, doi:10.1002/hep.26753 (2014).
33. Roskams, T. A. et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 39, 1739-1745, doi:10.1002/hep.20130 (2004).
34. Roskams, T. et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. The American journal of pathology 163, 1301-1311 (2003).
35. Clouston, A. D. et al. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 41, 809-818, doi:10.1002/hep.20650 (2005).
36. Weng, H. L. et al. IFN-gamma inhibits liver progenitor cell proliferation in HBV-infected patients and in 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-fed mice. Journal of hepatology 59, 738-745, doi:10.1016/j.jhep.2013.05.041 (2013).
37. Richardson, M. M. et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 133, 80-90 (2007).
38. Gadd, V. L. et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology 59, 1393-1405, doi:10.1002/hep.26937 (2014).
39. Wood, M. J., Gadd, V. L., Powell, L. W., Ramm, G. A. & Clouston, A. D. Ductular reaction in hereditary hemochromatosis: the link between hepatocyte senescence and fibrosis progression. Hepatology 59, 848-857, doi:10.1002/hep.26706 (2014).
40. Matthews, V. B., Klinken, E. & Yeoh, G. C. Direct effects of interleukin-6 on liver progenitor oval cells in culture. Wound repair and regeneration: official publication of the Wound Healing Society [and] the European Tissue Repair Society 12, 650-656, doi:10.1111/j.1067-1927.2004.12605.x (2004).
41. Jakubowski, A. et al. TWEAK induces liver progenitor cell proliferation. The Journal of clinical investigation 115, 2330-2340, doi:10.1172/JCI23486 (2005).
42. Nguyen, L. N. et al. Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology 45, 31-41, doi:10.1002/hep.21466 (2007).
43. Knight, B., Lim, R., Yeoh, G. C. & Olynyk, J. K. Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury. Journal of hepatology 47, 826-833, doi:S0168-8278(07)00470-9 [pii].
44. Campbell, J. S. et al. Expression of suppressors of cytokine signaling during liver regeneration. The Journal of clinical investigation 107, 1285-1292, doi:10.1172/JCI11867 (2001).
45. Jung, Y., Oh, S. H., Witek, R. P. & Petersen, B. E. Somatostatin stimulates the migration of hepatic oval cells in the injured rat liver. Liver international: official journal of the International Association for the Study of the Liver 32, 312-320, doi:10.1111/j.1478-3231.2011.02642.x (2012).
46. Jung, Y. et al. Signals from dying hepatocytes trigger growth of liver progenitors. Gut 59, 655-665, doi:10.1136/gut.2009.204354 (2010).
47. Cassiman, D. et al. The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3. The American journal of pathology 161, 521-530, doi:10.1016/S0002-9440(10)64208-3 (2002).
48. Tirnitz-Parker, J. E. et al. Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells. Hepatology 52, 291-302, doi:10.1002/hep.23663 (2010).
49. Yeoh, G. C. et al. Opposing roles of gp130-mediated STAT-3 and ERK-1/2 signaling in liver progenitor cell migration and proliferation. Hepatology 45, 486-494, doi:10.1002/hep.21535 (2007).
50. Boulter, L. et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nature medicine 18, 572-579, doi:10.1038/nm.2667 (2012).
51. Spee, B. et al. Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling. Gut 59, 247-257, doi:10.1136/gut.2009.188367 (2010).
52. Sicklick, J. K. et al. Hedgehog signaling maintains resident hepatic progenitors throughout life. American journal of physiology. Gastrointestinal and liver physiology 290, G859-870, doi:10.1152/ajpgi.00456.2005 (2006).
53. Omenetti, A. & Diehl, A. M. The adventures of sonic hedgehog in development and repair. II. Sonic hedgehog and liver development, inflammation, and cancer. American journal of physiology. Gastrointestinal and liver physiology 294, G595-598, doi:10.1152/ajpgi.00543.2007 (2008).
54. Omenetti, A. et al. Hedgehog signaling regulates epithelialmesenchymal transition during biliary fibrosis in rodents and humans. The Journal of clinical investigation 118, 3331-3342, doi:10.1172/JCI35875 (2008).
55. Omenetti, A. et al. Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology 50, 518-527, doi:10.1002/hep.23019 (2009).
56. Best, J. et al. Role of liver progenitors in acute liver injury. Frontiers in physiology 4, 258, doi:10.3389/fphys.2013.00258 (2013).
57. Williams, M. J., Clouston, A. D. & Forbes, S. J. Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. Gastroenterology 146, 349-356, doi:10.1053/j.gastro.2013.11.034 (2014).
58. Dechene, A. et al. Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology 52, 1008-1016, doi:10.1002/hep.23754 (2010).
59. Katoonizadeh, A. et al. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut 59, 1561-1569, doi:10.1136/gut.2009.189639 (2010).
60. Katoonizadeh, A., Nevens, F., Verslype, C., Pirenne, J. & Roskams, T. Liver regeneration in acute severe liver impairment: a clinicopathological correlation study. Liver international: official journal of the International Association for the Study of the Liver 26, 1225-1233, doi:10.1111/j.1478-3231.2006.01377.x (2006).
61. Rastogi, A. et al. Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF). Virchows Archiv: an international journal of pathology 459, 121-127, doi:10.1007/s00428-011-1115-9 (2011).
62. Fausto, N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39, 1477-1487, doi:10.1002/hep.20214 (2004).
63. Fausto, N., Campbell, J. S. & Riehle, K. J. Liver regeneration. Hepatology 43, S45-53, doi:10.1002/hep.20969 (2006).
64. Nissim, O. et al. Liver regeneration signature in hepatitis B virus (HBV)-associated acute liver failure identified by gene expression profiling. PloS one 7, e49611, doi:10.1371/journal.pone.0049611 (2012).
65. Roskams, T. Progenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus. Journal of hepatology 39, 431-434, doi:S0168827803003337 [pii] (2003).
66. Roskams, T. Relationships among stellate cell activation, progenitor cells, and hepatic regeneration. Clinics in liver disease 12, 853-860, ix, doi:S1089-3261(08)00083-4 [pii] 10.1016/j.cld.2008.07.014 (2008).
67. Possamai, L. A. et al. Role of monocytes and macrophages in experimental and human acute liver failure. World journal of gastroenterology: WJG 16, 1811-1819 (2010).
68. Wasmuth, H. E. et al. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. Journal of hepatology 42, 195-201, doi:10.1016/j.jhep.2004.10.019 (2005).
69. Kordes, C. & Haussinger, D. Hepatic stem cell niches. The Journal of clinical investigation 123, 1874-1880, doi:10.1172/JCI66027 (2013).
70. Kordes, C., Sawitza, I., Gotze, S., Herebian, D. & Haussinger, D. Hepatic stellate cells contribute to progenitor cells and liver regeneration. The Journal of clinical investigation 124, 5503-5515, doi:10.1172/JCI74119 (2014).
71. Wynn, T. A. Cellular and molecular mechanisms of fibrosis. J Pathol 214, 199-210, doi:10.1002/path.2277 (2008).
72. Van Hul, N. K., Abarca-Quinones, J., Sempoux, C., Horsmans, Y. & Leclercq, I. A. Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury. Hepatology 49, 1625-1635, doi:10.1002/hep.22820 (2009).
73. Van Hul, N. et al. Kupffer cells influence parenchymal invasion and phenotypic orientation, but not the proliferation, of liver progenitor cells in a murine model of liver injury. The American journal of pathology 179, 1839-1850, doi:10.1016/j.ajpath.2011.06.042 (2011).
74. Liu, Q. et al. Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. Journal of gastroenterology and hepatology 22, 2101-2106, doi:10.1111/j.1440-1746.2006.04362.x (2007).
75. Sarin, S. K. et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatology international 3, 269-282, doi:10.1007/s12072-008-9106-x (2009).
76. Canbay, A. et al. Acute liver failure: a life-threatening disease. Deutsches Arzteblatt international 108, 714-720, doi:10.3238/arztebl.2011.0714 (2011).
77. Moreau, R. et al. Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis. Gastroenterology 144, 1426-1437 e1429, doi:10.1053/j.gastro.2013.02.042 (2013).
78. Jalan, R. et al. Toward an improved definition of acute-on-chronic liver failure. Gastroenterology 147, 4-10, doi:10.1053/j.gastro.2014.05.005 (2014).
79. Jalan, R. et al. Acute-on chronic liver failure. Journal of hepatology 57, 1336-1348, doi:10.1016/j.jhep.2012.06.026 (2012).
80. Laleman, W. et al. Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert review of gastroenterology & hepatology 5, 523-537; quiz 537, doi:10.1586/egh.11.47 (2011).
81. Gines, P., Fernandez, J., Durand, F. & Saliba, F. Management of critically-ill cirrhotic patients. Journal of hepatology 56 Suppl 1, S13-24, doi:10.1016/S0168-8278(12)60003-8 (2012).
82. Olson, J. C. & Kamath, P. S. Acute-on-chronic liver failure: concept, natural history, and prognosis. Current opinion in critical care 17, 165-169, doi:10.1097/MCC.0b013e328344b42d (2011).
83. Brenner, D. A. Reversibility of liver fibrosis. Gastroenterology & hepatology 9, 737-739 (2013).
84. Desmet, V. J. & Roskams, T. Reversal of cirrhosis: evidence-based medicine?. Gastroenterology 125, 629-630; author reply 630-631, doi:S0016508503009739 [pii] (2003).
85. Wanless, I. R., Liu, J. J. & Butany, J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology 21, 1232-1237 (1995).
86. Wanless, I. R., Nakashima, E. & Sherman, M. Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. Archives of pathology & laboratory medicine 124, 1599-1607, doi:10.1043/0003-9985(2000)124<1599:ROHC>2.0.CO;2 (2000).
87. Boyer, J. L. & Klatskin, G. Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). The New England journal of medicine 283, 1063-1071, doi:10.1056/NEJM197011122832001 (1970).
88. Dechene, A. et al. Mini-laparoscopy guided liver biopsy increases diagnostic accuracy in acute liver failure. Digestion 90, 240-247, doi:10.1159/000366517 (2014).
89. Samuel, D. & Ichai, P. Prognosis indicator in acute liver failure: Is there a place for cell death markers?. Journal of hepatology 53, 593-595, doi:10.1016/j.jhep.2010.06.002 (2010).
90. O'Grady, J. G., Alexander, G. J., Hayllar, K. M. & Williams, R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97, 439-445 (1989).
91. Bismuth, H. et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Annals of surgery 222, 109-119 (1995).
92. Malinchoc, M. et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31, 864-871, doi:10.1053/he.2000.5852 (2000).
93. Bechmann, L. P. et al. Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. Journal of hepatology 53, 639-647, doi:10.1016/j.jhep.2010.04.029 (2010).
94. Takebe, T. et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499, 481-484, doi:10.1038/nature12271 (2013).
95. Michalopoulos, G. K., Grompe, M. & Theise, N. D. Assessing the potential of induced liver regeneration. Nature medicine 19, 1096-1097, doi:10.1038/nm.3325 (2013).
96. Theise, N. D., Dolle, L. & Kuwahara, R. Low hepatocyte repopulation from stem cells: a matter of hepatobiliary linkage not massive production. Gastroenterology 145, 253-254, doi:10.1053/j.gastro.2013.02.052 (2013).